Cargando…

Modularity of the metabolic gene network as a prognostic biomarker for hepatocellular carcinoma

Abnormal metabolism is an emerging hallmark of cancer. Cancer cells utilize both aerobic glycolysis and oxidative phosphorylation (OXPHOS) for energy production and biomass synthesis. Understanding the metabolic reprogramming in cancer can help design therapies to target metabolism and thereby to im...

Descripción completa

Detalles Bibliográficos
Autores principales:	Ye, Fengdan, Jia, Dongya, Lu, Mingyang, Levine, Herbert, Deem, Michael W.
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Impact Journals LLC 2018
Materias:	Research Paper
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5871093/ https://www.ncbi.nlm.nih.gov/pubmed/29599922 http://dx.doi.org/10.18632/oncotarget.24551

Ejemplares similares

Identification of Key Genes in Purine Metabolism as Prognostic Biomarker for Hepatocellular Carcinoma
por: Su, Wen-Jing, et al.
Publicado: (2021)

RACIPE: a computational tool for modeling gene regulatory circuits using randomization
por: Huang, Bin, et al.
Publicado: (2018)

Interrogating the topological robustness of gene regulatory circuits by randomization
por: Huang, Bin, et al.
Publicado: (2017)

Machine-learning approach to the design of OSDAs for zeolite beta
por: Daeyaert, Frits, et al.
Publicado: (2019)

Decoding the mechanisms underlying cell-fate decision-making during stem cell differentiation by random circuit perturbation
por: Huang, Bin, et al.
Publicado: (2020)

Cell Cycle Genes Are Potential Diagnostic and Prognostic Biomarkers in Hepatocellular Carcinoma
por: Liping, Xu, et al.
Publicado: (2020)

Predict New Therapeutic Drugs for Hepatocellular Carcinoma Based on Gene Mutation and Expression
por: Yu, Liang, et al.
Publicado: (2020)

Identification of lipid metabolism-associated genes as prognostic biomarkers based on the immune microenvironment in hepatocellular carcinoma
por: Gu, Xiangqian, et al.
Publicado: (2022)

Decoding the coupled decision-making of the epithelial-mesenchymal transition and metabolic reprogramming in cancer
por: Galbraith, Madeline, et al.
Publicado: (2022)

Spindle and Kinetochore-associated Family Genes are Prognostic and Predictive Biomarkers in Hepatocellular Carcinoma
por: Cai, Chenhui, et al.
Publicado: (2022)

Corrigendum to “Cell Cycle Genes Are Potential Diagnostic and Prognostic Biomarkers in Hepatocellular Carcinoma”
por: Liping, Xu, et al.
Publicado: (2020)

Prognostic roles of metabolic reprogramming-associated genes in patients with hepatocellular carcinoma
por: Cui, Lijuan, et al.
Publicado: (2020)

Elucidating the Metabolic Plasticity of Cancer: Mitochondrial Reprogramming and Hybrid Metabolic States
por: Jia, Dongya, et al.
Publicado: (2018)

Prognostic Score-based Clinical Factors and Metabolism-related Biomarkers for Predicting the Progression of Hepatocellular Carcinoma
por: Yan, Jia, et al.
Publicado: (2020)

Prognostic Role and Potential Mechanisms of the Ferroptosis-Related Metabolic Gene Signature in Hepatocellular Carcinoma
por: Dai, Tianxing, et al.
Publicado: (2021)

Weighted Gene Coexpression Network Analysis Reveals the Dynamic Transcriptome Regulation and Prognostic Biomarkers of Hepatocellular Carcinoma
por: Qu, Shuping, et al.
Publicado: (2020)

A novel seven-gene signature as Prognostic Biomarker in Hepatocellular Carcinoma
por: Xie, Hui, et al.
Publicado: (2020)

Identification of PLOD Family Genes as Novel Prognostic Biomarkers for Hepatocellular Carcinoma
por: Yang, Bo, et al.
Publicado: (2020)

Screening Hub Genes as Prognostic Biomarkers of Hepatocellular Carcinoma by Bioinformatics Analysis
por: Zhou, Zengyuan, et al.
Publicado: (2019)

Novel Gene Signatures as Prognostic Biomarkers for Predicting the Recurrence of Hepatocellular Carcinoma
por: Son, Ju A, et al.
Publicado: (2022)

N7-Methylguanosine Genes Related Prognostic Biomarker in Hepatocellular Carcinoma
por: Regmi, Parbatraj, et al.
Publicado: (2022)

MARCKS is a New Prognostic Biomarker in Hepatocellular Carcinoma
por: Lu, Haoran, et al.
Publicado: (2023)

Analysis of Hierarchical Organization in Gene Expression Networks Reveals Underlying Principles of Collective Tumor Cell Dissemination and Metastatic Aggressiveness of Inflammatory Breast Cancer
por: Tripathi, Shubham, et al.
Publicado: (2018)

A Novel Metabolism-Related Signature as a Candidate Prognostic Biomarker for Hepatocellular Carcinoma
por: Wang, Zhihao, et al.
Publicado: (2021)

Modular co-evolution of metabolic networks
por: Zhao, Jing, et al.
Publicado: (2007)

Integrated analysis of competing endogenous RNA network revealing potential prognostic biomarkers of hepatocellular carcinoma
por: Liao, Xiwen, et al.
Publicado: (2019)

Regulation Network and Prognostic Significance of Aldo-Keto Reductase (AKR) Superfamily Genes in Hepatocellular Carcinoma
por: Dai, Tianxing, et al.
Publicado: (2021)

Identification of novel prognostic biomarkers in the TF-enhancer-target regulatory network in hepatocellular carcinoma and immune infiltration analysis
por: Yan, Jianing, et al.
Publicado: (2023)

Coordinated modular functionality and prognostic potential of a heart failure biomarker-driven interaction network
por: Azuaje, Francisco, et al.
Publicado: (2010)

Prognostic Biomarker Identification Through Integrating the Gene Signatures of Hepatocellular Carcinoma Properties
por: Cai, Jialin, et al.
Publicado: (2017)

Cell Division Cycle Associated Genes as Diagnostic and Prognostic Biomarkers in Hepatocellular Carcinoma
por: Jiang, Shan-Shan, et al.
Publicado: (2021)

Nucleoporin 107 is a prognostic biomarker in hepatocellular carcinoma associated with immune infiltration
por: Nong, Ju‐sen, et al.
Publicado: (2023)

OSlihc: An Online Prognostic Biomarker Analysis Tool for Hepatocellular Carcinoma
por: An, Yang, et al.
Publicado: (2020)

Prediction of hepatocellular carcinoma risk in patients with chronic liver disease from dynamic modular networks
por: Chen, Yinying, et al.
Publicado: (2021)

Implications of the Hybrid Epithelial/Mesenchymal Phenotype in Metastasis
por: Jolly, Mohit Kumar, et al.
Publicado: (2015)

Fidgetin as a potential prognostic biomarker for hepatocellular carcinoma
por: Zhou, Bin, et al.
Publicado: (2020)

AURKB as a Promising Prognostic Biomarker in Hepatocellular Carcinoma
por: Xiao, Jingchuan, et al.
Publicado: (2021)

Identification and Validation of Novel Biomarkers for Diagnosis and Prognosis of Hepatocellular Carcinoma
por: Hu, Xiaoyi, et al.
Publicado: (2020)

Copy number variations of MMP-9 are prognostic biomarkers for hepatocellular carcinoma
por: Yu, Xi, et al.
Publicado: (2020)

Exonuclease 1 is a Potential Diagnostic and Prognostic Biomarker in Hepatocellular Carcinoma
por: Ma, Jiaxiu, et al.
Publicado: (2022)

Cannot write session to /tmp/vufind_sessions/sess_epf3mv5j4r56q0u0k6etoo4snq